Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response-Reference-Cited by-同舟云学术

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response

Published:2018-09-26 Issue:1 Volume:38 Page:60
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Zhang Feifei¹,Wang Wenjie¹,Long Yuan¹,Liu Hui¹,Cheng Jijun¹,Guo Lin¹,Li Rongyu¹,Meng Chao¹,Yu Shan¹,Zhao Qingchuan²,Lu Shun³,Wang Lili⁴,Wang Haitao⁴,Wen Danyi¹

Affiliation:

1. Shanghai LIDE Biotech Co., LTD; Shanghai 201203 P. R. China

2. Department of Surgery; Xijing Hospital, The Fourth Military Medical University; Xi'an 710032 P. R. China

3. Department of Oncology; Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University; Shanghai 200030 P. R. China

4. The Second Hospital of Tianjin Medical University; Tianjin Key Laboratory of Urology; Tianjin 300211 P. R. China

Funder

Renji Hospital, School of Medicine

Shanghai Jiao Tong University

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s40880-018-0329-5.pdf

Reference39 articles.

1. Functional precision cancer medicine-moving beyond pure genomics;Letai;Nat Med.,2017

2. Personalized in vitro and in vivo cancer models to guide precision medicine;Pauli;Cancer Discov,2017

3. Precision medicine for cancer with next-generation functional diagnostics;Friedman;Nat Rev Cancer,2015

4. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers;Vlachogiannis;Science,2018

5. Tumor evolution and drug response in patient-derived organoid models of bladder cancer;Lee;Cell,2018

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

2. Amelanotic primary cervical malignant melanoma: A case report and review of literature;World Journal of Clinical Oncology;2024-07-24

3. Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models;npj Breast Cancer;2024-06-05

4. FBXO22 is a potential therapeutic target for recurrent chondrosarcoma;Journal of Bone Oncology;2024-06

5. Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response;EBIOMEDICINE;2024